Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Stansbury, Melanie A. [D-NM-1]

Rep. Stansbury, Melanie A. [D-NM-1]

United States · Official source

Records

1,678 records where Rep. Stansbury, Melanie A. [D-NM-1] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9222 (119th)referred

Drain the Swamp Act

United States · United States Congress · 9 June 2026

Resolution· HCONRESH.Con.Res. 108 (119th)passed

Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from hostilities in Lebanon.

United States · United States Congress · 3 June 2026

This concurrent resolution directs the President to remove U.S. Armed Forces from hostilities in Lebanon within seven days of the resolution's adoption. The resolution specifies that it shall not be construed to prevent or limit security cooperation with the Lebanese Armed Forces or the protection of diplomatic facilities.

Bill· HRH.R. 9021 (119th)referred

Stay Cool Act

United States · United States Congress · 22 May 2026

Bill· HRH.R. 9002 (119th)referred

SURS Extension Act

United States · United States Congress · 21 May 2026

Small Practice, Underserved, and Rural Support Program Extension Act of 2023 or the SURS Extension Act This bill reauthorizes funds through FY2031 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)

Bill· HRH.R. 8967 (119th)referred

Rural Community Hospital Demonstration Program Reauthorization

United States · United States Congress · 21 May 2026

Rural Community Hospital Demonstration Program Reauthorization This bill extends the Rural Community Hospital Demonstration Program for an additional five years. The program tests the feasibility of cost-based reimbursement under Medicare for small rural hospitals that are too large to qualify for special payment as critical access hospitals. The bill specifies that hospitals that participate in the program between December 30, 2024, and January 1, 2027, may continue to participate during the five-year extension period.

Bill· HRH.R. 8896 (119th)referred

Loan Forgiveness for Educators Act of 2026

United States · United States Congress · 19 May 2026

Loan Forgiveness for Educators Act of 2026 This bill expands loan forgiveness for educators by revising the Teacher Loan Forgiveness Program. The program provides loan forgiveness (up to $17,500) for teachers who are highly qualified, teach full-time in a low-income elementary or secondary school or educational service agency, and complete five years of consecutive service. Specifically, the bill renames the program as the Educator Loan Forgiveness Programs. Additionally, the bill expands the program by making additional loan types eligible for benefits under the program (e.g., Parent PLUS Loans). Further, the bill expands program eligibility to early childhood educators and program directors serving in early childhood education programs and school leaders serving in public high-need schools. The bill requires the Department of Education to make monthly student loan payments on behalf of the educator during qualifying service (i.e., employment as a full-time qualifying educator in a high-need school or an early childhood education program), provide complete loan forgiveness after five years of qualifying service (which does not have to be consecutive), and take steps to notify borrowers about changes to the program.

Bill· HRH.R. 8907 (119th)referred

IMPACT to Save Moms Act

United States · United States Congress · 19 May 2026

Innovative Maternal Payment and Coverage To Save Moms Act or the IMPACT to Save Moms Act This bill requires the Centers for Medicare & Medicaid Services to establish the Perinatal Care Alternative Payment Model Demonstration Project through FY2031 to allow states to test payment models for maternity care, including postpartum care, under Medicaid and the Children's Health Insurance Program (CHIP). 

Bill· HRH.R. 8910 (119th)referred

SLUSH FUND Act of 2026

United States · United States Congress · 19 May 2026

Bill· HRH.R. 8811 (119th)referred

Moms Matter Act

United States · United States Congress · 14 May 2026

Bill· HRH.R. 8742 (119th)referred

Respect Tribal IDs Act

United States · United States Congress · 12 May 2026

Bill· HRH.R. 8667 (119th)referred

MISSION Rx Act

United States · United States Congress · 7 May 2026

Resolution· HRESH.Res. 1251 (119th)passed

Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community.

United States · United States Congress · 30 April 2026

This resolution calls on elected officials, faith leaders, and civil society leaders to condemn and counter acts of anti-Semitism. The resolution also honors the contributions of Jewish-American servicemembers and commits to ensuring all Americans, including Jewish Americans, can worship without fear of violence or persecution.

Bill· HRH.R. 8592 (119th)referred

No WAR Act

United States · United States Congress · 30 April 2026

No War Appropriations through Reconciliation Act or the No WAR Act This bill establishes a budget point of order that prohibits considering reconciliation legislation that provides funding for unauthorized military force against Iran. (Reconciliation is an expedited method by which Congress may adopt changes in spending and revenue laws to achieve the budgetary goals reflected in a congressional budget resolution. Reconciliation bills are considered by Congress using expedited legislative procedures that prevent a filibuster and restrict amendments in the Senate.) Specifically, the point of order may be raised to prohibit the consideration of reconciliation legislation that provides budget authority for hostilities, including hostilities conducted by a proxy force, against Iran unless Congress has authorized such hostilities through a declaration of war or a specific authorization for use of military force. Under the bill, hostilities includes any offensive military operation, strike, covert action, or sustained engagement involving armed conflict against Iranian military forces, territory, or government institutions.  The point of order may be waived by a vote of at least three-fifths of all Senators duly chosen and sworn (60 votes if there are no vacancies).

Bill· HRH.R. 8606 (119th)referred

CHARTER Act

United States · United States Congress · 30 April 2026

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.